102 related articles for article (PubMed ID: 15688412)
1. Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.
Mathieu A; Clerc P; Portolan G; Bierkamp C; Lulka H; Pradayrol L; Seva C; Fourmy D; Dufresne M
Int J Cancer; 2005 May; 115(1):46-54. PubMed ID: 15688412
[TBL] [Abstract][Full Text] [Related]
2. Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo.
Bierkamp C; Bonhoure S; Mathieu A; Clerc P; Fourmy D; Pradayrol L; Seva C; Dufresne M
Am J Pathol; 2004 Dec; 165(6):2135-45. PubMed ID: 15579455
[TBL] [Abstract][Full Text] [Related]
3. Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia.
Clerc P; Leung-Theung-Long S; Wang TC; Dockray GJ; Bouisson M; Delisle MB; Vaysse N; Pradayrol L; Fourmy D; Dufresne M
Gastroenterology; 2002 Feb; 122(2):428-37. PubMed ID: 11832457
[TBL] [Abstract][Full Text] [Related]
4. Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas.
Gigoux V; Clerc P; Sanchez D; Coll MG; Corominola H; Leung-Theung-Long S; Pénicaud L; Gomis R; Seva C; Fourmy D; Dufresne M
Regul Pept; 2008 Feb; 146(1-3):88-98. PubMed ID: 17888528
[TBL] [Abstract][Full Text] [Related]
5. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
J Surg Res; 1996 Jun; 63(1):105-9. PubMed ID: 8661181
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice expressing cholecystokinin 2 receptors in the pancreas.
Clerc P; Saillan-Barreau C; Desbois C; Pradayrol L; Fourmy D; Dufresne M
Pharmacol Toxicol; 2002 Dec; 91(6):321-6. PubMed ID: 12688375
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas.
Ferrand A; Vatinel S; Kowalski-Chauvel A; Bertrand C; Escrieut C; Fourmy D; Dufresne M; Seva C
World J Gastroenterol; 2006 Jul; 12(28):4498-503. PubMed ID: 16874861
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
[TBL] [Abstract][Full Text] [Related]
9. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
10. The G-protein-coupled CCK2 receptor associates with phospholipase Cgamma1.
Arnould M; Tassa A; Ferrand A; Archer E; Estève JP; Pénalba V; Portolan G; Escherich A; Moroder L; Fourmy D; Seva C; Dufresne M
FEBS Lett; 2004 Jun; 568(1-3):89-93. PubMed ID: 15196926
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.
Visser CJ; de Weger RA; van Blokland WT; Seifert-Bock I; Kobrin MS; Korc M; Woutersen RA
Br J Cancer; 1996 Jul; 74(1):92-8. PubMed ID: 8679465
[TBL] [Abstract][Full Text] [Related]
13. Effect of hypergastrinemia on pancreatic carcinogenesis.
McDonald JM; Longnecker DS; Bell RH
Am J Surg; 2002 Apr; 183(4):441-4. PubMed ID: 11975934
[TBL] [Abstract][Full Text] [Related]
14. Increased immunoreactivity and protein tyrosine kinase activity of the protooncogene pp60c-src in preneoplastic lesions in rat pancreas.
Visser CJ; Rijksen G; Woutersen RA; De Weger RA
Lab Invest; 1996 Jan; 74(1):2-11. PubMed ID: 8569183
[TBL] [Abstract][Full Text] [Related]
15. [Differential genetic pathway of duct and acinar carcinomas of the pancreas].
Tsutsumi M
Gan To Kagaku Ryoho; 2005 May; 32(5):593-8. PubMed ID: 15918556
[TBL] [Abstract][Full Text] [Related]
16. Exclusion of cellular iron and reduced gamma-glutamyl transpeptidase activity in rat pancreas acinar cell hyperplastic nodules and adenomas induced by azaserine.
Mori H; Tanaka T; Takahashi M; Williams GM
Gan; 1983 Aug; 74(4):497-501. PubMed ID: 6138291
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells.
Cayrol C; Clerc P; Bertrand C; Gigoux V; Portolan G; Fourmy D; Dufresne M; Seva C
Oncogene; 2006 Jul; 25(32):4421-8. PubMed ID: 16547500
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
[TBL] [Abstract][Full Text] [Related]
19. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas.
Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS
Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
